1. Mutational landscape of gastric adenocarcinoma in Latin America: A genetic approach for precision medicine
- Author
-
Yesennia Sánchez-Pérez, Yolanda I. Chirino, Miguel Santibáñez-Andrade, Diddier Prada, Claudia M. García-Cuellar, Octavio Alonso Larraga, Dennis Cerrato-Izaguirre, Javier Camacho, and Angélica Hernández-Guerrero
- Subjects
0301 basic medicine ,Genetics ,education.field_of_study ,Latin Americans ,Population ,Cell Biology ,Biology ,Precision medicine ,medicine.disease_cause ,Biochemistry ,Germline ,03 medical and health sciences ,Gastric adenocarcinoma ,030104 developmental biology ,0302 clinical medicine ,030220 oncology & carcinogenesis ,medicine ,Data compilation ,KRAS ,education ,Molecular Biology ,TCF7L2 ,Genetics (clinical) - Abstract
Latin-America (LATAM) is the second region in gastric cancer incidence; gastric adenocarcinoma (GA) represents 95% of all cases. We provide a mutational landscape of GA highlighting a) germline pathogenic variants associated with hereditary GA, b) germline risk variants associated with sporadic GA, and c) somatic variants present in sporadic GA in LATAM and, analyze how this landscape can be applied for precision medicine. We found that Brazil, Chile, Colombia, Mexico, Peru, and Venezuela are the countries with more published studies from LATAM explicitly related to GA. Our analysis displayed that different germline pathogenic variants for the CDH1 gene have been identified for hereditary GA in Brazilian, Chilean, Colombian, and Mexican populations. An increased risk of developing somatic GA is associated with the following germline risk variants: IL-4, IL-8, TNF-α, PTGS2, NFKB1, RAF1, KRAS, MAPK1 in Brazilian; IL-10 in Chilean; IL-10 in Colombian; EGFR, ERRB2 in Mexican and TCF7L2, Chr8q24 in Venezuelan population. The path from mutational landscape to precision medicine requires four development levels: 1) Data compilation, 2) Data analysis and integration, 3) Development and approval of clinical approaches, and 4) Population benefits. Generating local genomic information is the initial padlock to overcome to generate and apply precision medicine.
- Published
- 2022
- Full Text
- View/download PDF